1. Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?. (December 2018) Authors: Remon, J.; Hendriks, L.E.; Cabrera, C.; Reguart, N.; Besse, B. Journal: Cancer treatment reviews Issue: Volume 71(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer. (August 2019) Authors: Lindsay, C.R.; Blackhall, F.H.; Carmel, A.; Fernandez-Gutierrez, F.; Gazzaniga, P.; Groen, H.J.M.; Hiltermann, T.J.N.; Krebs, M.G.; Loges, S.; López-López, R.; Muinelo-Romay, L.; Pantel, K.; Priest, L.; Riethdorf, S.; Rossi, E.; Terstappen, L.; Wikman, H.; Soria, J.-C.; Farace, F.; Renehan, A. Journal: European journal of cancer Issue: Volume 117(2019) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ASSOCIATION OF LIPI SCORE WITH IMMUNOTHERAPY OUTCOMES IN ELDERLY POPULATION. (November 2019) Authors: Belmaachi, A.; Auclin, E.; Vincent, H.; Varga, A.; Romano, P.Martin; Vuagnat, P.; Pérez, L.Mezquita; Besse, B.; Planchard, D.; Hollebecque, A.; Champiat, S.; Marabelle, A.; Massard, C.; Baldini, C. Journal: Journal of geriatric oncology Issue: Volume 10(2019)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 143TiPSPECTALUNG: SCREENING PATIENTS WITH THORACIC TUMORS FOR EFFICIENT CLINICAL TRIAL ACCESS. (16th March 2015) Authors: Besse, B.; Menis, J.; Adam, J.; Dziadziuszko, R.; Hasan, B.; Lacroix, L.; Peters, S.; Lacombe, D.A.; O'Brien, M.; Stahel, R.A. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 1 Page Start: i44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. LBA51Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E–mutant metastatic non-small cell lung cancer (NSCLC). (18th September 2017) Authors: Planchard, D.; Smit, E.F.; Groen, H.J.M.; Mazieres, J.; Besse, B.; Helland, Å.; Giannone, V.; D'Amelio, A.; Zhang, P.; Mookerjee, B.; Johnson, B. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts. (August 2020) Authors: Früh, M.; Panje, C.M.; Reck, M.; Blackhall, F.; Califano, R.; Cappuzzo, F.; Besse, B.; Novello, S.; Garrido, P.; Felip, E.; O'Brien, M.; Paz Ares, L.; de Marinis, F.; Westeel, V.; De Ruysscher, D.; Putora, P.M. Journal: Lung cancer Issue: Volume 146(2020) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Thymic malignancies: Moving forward with new systemic treatments. (May 2016) Authors: Remon, J.; Lindsay, C.R.; Bluthgen, M.V.; Besse, B. Journal: Cancer treatment reviews Issue: Volume 46(2016) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC). (September 2015) Authors: Besse, B.; Johnson, M.; Janne, P.A.; Garassino, M.; Eberhardt, W.E.E.; Besse, B.; Johnson, M.; Janne, P.A.; Garassino, M.; Eberhardt, W.E.E.; Peters, S.; Toh, C.K.; Kurata, T.; Li, Z.; Kowanetz, M.; Mocci, S.; Sandler, A.; Rizvi, N.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA. (May 2022) Authors: Remon, Jordi; Lacas, Benjamin; Herbst, Roy; Reck, Martin; Garon, Edward B.; Scagliotti, Giorgio V.; Ramlau, Rodryg; Hanna, Nasser; Vansteenkiste, Johan; Yoh, Kiyotaka; Groen, Harry J.M.; Heymach, John V.; Mandrekar, Sumithra J.; Okamoto, Isamu; Neal, Joel W.; Heist, Rebecca S.; Planchard, David; ... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Molecular testing in older patients treated for an advanced or metastatic nonsquamous non-small-cell lung cancer. (December 2021) Authors: Lamy, T.; Cabarrou, B.; Planchard, D.; Quantin, X.; Schneider, S.; Bringuier, M.; Robain, M.; Besse, B.; Simon, G.; Baldini, C. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗